Chemoinformaics analysis of cyanidin-3,5-diglucoside
| Molecular Weight | 611.529 | nRot | 7 |
| Heavy Atom Molecular Weight | 580.281 | nRig | 29 |
| Exact Molecular Weight | 611.161 | nRing | 5 |
| Solubility: LogS | -2.702 | nHRing | 3 |
| Solubility: LogP | -1.2 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 3 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 74 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 43 | No. of Aromatic Carbocycles | 2 |
| nHetero | 16 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 31 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 16 | No. of Arom Bond | 17 |
| nHA | 15 | APOL | 78.5926 |
| nHD | 11 | BPOL | 39.7794 |
| QED | 0.1 |
| Synth | 4.943 |
| Natural Product Likeliness | 1.61 |
| NR-PPAR-gamma | 0.677 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.962 |
| HIA | 0.963 |
| CACO-2 | -6.494 |
| MDCK | 0.000107559 |
| BBB | 0.465 |
| PPB | 0.768085 |
| VDSS | 0.71 |
| FU | 0.291125 |
| CYP1A2-inh | 0.018 |
| CYP1A2-sub | 0.012 |
| CYP2c19-inh | 0.003 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.114 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.164 |
| CYP3a4-inh | 0.003 |
| CYP3a4-sub | 0.001 |
| CL | 1.89 |
| T12 | 0.557 |
| hERG | 0.008 |
| Ames | 0.478 |
| ROA | 0.067 |
| SkinSen | 0.018 |
| Carcinogencity | 0.123 |
| EI | 0.006 |
| Respiratory | 0.011 |
| NR-Aromatase | 0.896 |
| Antiviral | Yes |
| Prediction | 0.808284 |